435
Downloads
4
Episodes
In this podcast series from the University of East Anglia, we speak to the incredible individuals carrying out the University's pioneering work as part of the Dare to Do Different campaign, the visionary donors who make it possible and the people whose lives could be transformed as a result.
Episodes
Sep 21, 2021
Sep 21, 2021
24 min
In the first episode of our new series, we speak to world-leading cancer geneticist, Professor Colin Cooper, who is working to revolutionise the way we diagnose prostate cancer and help men avoid life-altering but often unnecessary treatments.
We also hear from Trevor Beckford, who shares his frank and honest experience of being diagnosed with prostate cancer and the impact that a prostatectomy has had on his life.
Sep 28, 2021
Sep 28, 2021
36 min
In our second episode of the Pioneer Podcast, we are joined by the genius minds behind prostate cancer research at UEA.
We delve into the detail of the UEA prostate cancer tests, how they work and how they could make a difference to lives around the world.
And we hear more from Trevor Beckford as he shares his personal story of his prostate cancer diagnosis.
Mar 1, 2022
Mar 1, 2022
33 min
In our final prostate cancer episode, we are back with Trevor Beckford who is taking us through his experience of prostate cancer diagnosis process in the UK.
Prof Colin Cooper shares details of the next phase in his research and how philanthropy could get him get there.
And we chat to Paul Jackson, the expert behind the setting up of the diagnostic screening laboratory, a vital step towards proving UEA’s revolutionary diagnostic tests for prostate cancer in clinical trials and getting an accredited test into the hands of clinicians across the world.
Jun 16, 2026
Jun 16, 2026
31 min
In this episode, we return to Professor Colin Cooper and UEA’s prostate cancer research team to hear about the latest developments in their work since our last visit in 2021.
Colin takes us inside the lab and shares the latest on the at-home Prostate Urine Risk (PUR) Test and the Tiger Test, while Paul Jackson explains why laboratory accreditation is essential before the tests can be used in patient care.
We also hear about the team’s research into the possible role of bacteria in aggressive prostate cancer, alongside new understanding that prostate cancer may be two distinct diseases, and how support from patients, charities and philanthropists has helped move this work forward.